Imaging Technology

X-Ray Induced Acoustic CT (XACT) Dosimetry

Developing a novel contrast agent for X-Ray Induced Acoustic CT (XACT) dosimetry, providing real-time in-vivo 3D calibrated radiation dose measurements.

Back to Projects
XACT Dosimetry Project

Project Overview

X-Ray Induced Acoustic Computed Tomography (XACT) is an emerging imaging modality that combines the principles of X-ray absorption and acoustic wave detection. Our research focuses on developing novel contrast agents for XACT to enable real-time, in-vivo 3D radiation dose measurements during radiation therapy.

The Challenge

Current radiation dosimetry methods have significant limitations: they either provide point measurements, require post-treatment analysis, or cannot be used in-vivo. This makes real-time adaptive radiation therapy challenging, as clinicians cannot directly observe the actual dose distribution within the patient during treatment.

Our Approach

We are developing a groundbreaking system that combines:

  • Novel nanoparticle-based contrast agents that enhance the XACT signal
  • Acoustic detection arrays optimized for clinical implementation
  • Advanced reconstruction algorithms for real-time 3D dose visualization
  • Integration with treatment planning systems for adaptive radiation therapy

Expected Outcomes

Our XACT dosimetry system aims to:

  • Provide real-time 3D visualization of radiation dose distribution
  • Enable adaptive radiation therapy based on actual delivered dose
  • Improve treatment accuracy and reduce normal tissue complications
  • Serve as a quality assurance tool for complex radiation treatments

Current Status

This project is currently in the early experimental phase. We have successfully synthesized and tested several candidate contrast agents in phantom studies and are now preparing for pre-clinical testing.

Research Team

DT

Dr. David Thomas

Principal Investigator

ME

Mohamed Eldib

Postdoctoral Researcher